HVIVO PLC on Tuesday set a new revenue target of GBP100 million by 2028, after a strong financial and operational performance last year.
The London-based firm is a specialist contract research.
HVIVO PLC on Tuesday said it signed a contract worth GBP6.3 million to test a potential treatment for the common cold.
hVIVO is a London-based specialist contract research organisation that tests.
Infectious and respiratory disease study group hVIVO has inked a £6.3m contract with an unnamed biotechnology client to test an antiviral candidate using its common cold virus human challenge study model.
Srinagar: As part of its 21-day foundation program, IRTIQA, Sher-e-Kashmir University of Agricultural Sciences and Technology of Kashmir organised a mehfil-e-mushaira (poetry recitation).
Besides the student poets of SKUAST-K, renowned poets of Kashmir participated in the Mushaira organised under the sponsorship of the World Bank-ICAR-funded National Agricultural Higher Education Project (NAHEP). Rashid Rahil and Abdul Ahad Farhad presided over the mehfil,
HVIVO PLC on Wednesday said it signed a deal with an unnamed existing client to test a respiratory syncytial virus antiviral drug candidate using its study model.
Shares in hVIVO were up 8.1% to.